G01N 2333/91045
Acyltransferases
Official title: Acyltransferases (2.3)
G01N2333/91045 (Acyltransferases) appears on 176 US grants and 339 published applications in this corpus.
Search patents in G01N- Granted patents
- 176
- Published applications
- 339
- Assignees
- 240
- Inventors
- 817
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 5 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 4 |
| 2002 | 3 | 4 |
| 2003 | 2 | 12 |
| 2004 | 9 | 6 |
| 2005 | 2 | 10 |
| 2006 | 3 | 12 |
| 2007 | 2 | 9 |
| 2008 | 2 | 6 |
| 2009 | 8 | 15 |
| 2010 | 8 | 18 |
| 2011 | 9 | 11 |
| 2012 | 9 | 12 |
| 2013 | 3 | 12 |
| 2014 | 7 | 15 |
| 2015 | 7 | 25 |
| 2016 | 6 | 11 |
| 2017 | 10 | 19 |
| 2018 | 12 | 16 |
| 2019 | 5 | 8 |
| 2020 | 10 | 13 |
| 2021 | 6 | 17 |
| 2022 | 8 | 22 |
| 2023 | 7 | 14 |
| 2024 | 3 | 17 |
| 2025 | 11 | 22 |
| 2026 | 6 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Combination of markers for predicting the response to Vx-0018 Sep 2026US 12,728,158 B2Kriptic Pharmaceuticals Limited
- Biological markers in the diagnosis of endometriosis4 Aug 2026US 12,699,103 B2Yeditepe Universitesi
- tTG-DGP biomarkers for monitoring celiac disease30 Jun 2026US 12,669,510 B2Mayo Foundation for Medical Education and Research
- Predicting prognosis and treatment response of breast cancer patients using expression and cellular localization of N-myristoyltransferase19 May 2026US 12,631,646 B2Oncodrex Inc.
- Methods for modulation of acetyltransferase activity and applications thereof including treatments12 May 2026US 12,625,139 B2The Board of Trustees of the Leland Stanford Junior University
- Lysine-free ubiquibody variants for long-lived intracellular protein silencing27 Aug 2026US 2026/0250647 A1
- Method of detecting target substance, reagent, and in vitro diagnostic kit20 Aug 2026US 2026/0242844 A1Canon Kabushiki Kaisha
- Protein complexes for proximity-based labeling of intracellular microenvironments16 Jul 2026US 2026/0202414 A1
- FRET Active E2-UBL Conjugates and Uses Thereof2 Jul 2026US 2026/0185137 A1Board of Regents, The University of Texas System
- Methods of controlled cleavage2 Jul 2026US 2026/0185996 A1Quantum-Si Incorporated
Most cited
By later US patents
- Monoclonal antibodies and detection methods for phosphinothricin-N-acetyl-transferase enzyme640US 9,371,394 B2Dow AgroSciences LLC · 2016
- Biomarkers and targets for diagnosis, prognosis and management of prostate disease113US 5,972,615 AUrocor, Inc. · 1999
- Biomarkers and targets for diagnosis prognosis and management of prostate disease91US 6,171,796 B2Urocor, Inc. · 2001
- Diagnosis of coeliac disease using a gliadin epitope59US 7,144,569 B1Isis Innovation Limited · 2006
- Pet leash with length-limited elastic section38US 5,873,328 A1999